| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |